Online Training - Limited number

22 March 2027

4 hours

Online

English

About

When pharmacovigilance activities are shared with external partners, how can a Marketing Authorisation Holder (MAH) ensure that responsibilities are effectively implemented, safety information is exchanged within the required timelines and regulatory compliance can be demonstrated?

Pharmacovigilance Agreements (PVAs) are an integral part of an effective pharmacovigilance system. They define the responsibilities of each party and provide a framework for managing safety-related activities, overseeing external partners and ensuring continuity throughout the relationship.

However, even well-defined agreements can present operational challenges. Unclear reporting timelines, gaps in communication, insufficient documentation or poorly managed provider transitions may compromise compliance and the timely handling of safety information.

This practical workshop focuses on the operational implementation and oversight of PVAs in EU post-marketing pharmacovigilance for human medicines. Through real-world scenarios and guided exercises, participants will explore how to translate agreement requirements into clear processes, identify potential compliance gaps and strengthen oversight of outsourced pharmacovigilance activities.

Programme

Pharmacovigilance Agreements: responsibilities and operational scope

  • The role of PVAs within the pharmacovigilance system
  • Defining responsibilities between the MAH and external partners
  • Mapping activities and accountability across distributors and service providers

Safety data exchange: managing timelines and responsibilities

  • Establishing day zero and distinguishing partner transfer deadlines from regulatory reporting timelines
  • Defining information transfer, receipt confirmation and escalation processes
  • Practical exercise: reviewing and improving a safety data exchange clause

Partner oversight and inspection readiness

  • Monitoring compliance with agreed responsibilities and timelines
  • Identifying gaps in documentation and evidence of compliance
  • Case study: investigating a late safety report and assessing corrective actions

Managing provider transitions and ensuring continuity

  • Managing responsibilities during changes of pharmacovigilance service providers
  • Reviewing database handover and outstanding safety cases
  • Practical exercise: assessing handover readiness and defining acceptance criteria

Key takeaways and discussion

  • Applying a practical checklist to review the operational adequacy of PVAs
  • Knowledge check and Q&A

This course is designed for Pharmacovigilance, Drug Safety, Quality Assurance and Regulatory Affairs professionals involved in the implementation, management or oversight of Pharmacovigilance Agreements.
It is also relevant for professionals responsible for vendor management, distribution and external partnerships who need to ensure that pharmacovigilance responsibilities are clearly defined, effectively implemented and appropriately monitored.

 

Participant’s experience

Basic familiarity with post-marketing drug safety reporting is helpful. Participants can complete all exercises without prior experience drafting agreements.

A live online workshop combining short explanations, polls, breakout discussions and an inspection simulation. Participants rewrite a clause, compare it with a model answer and apply a review checklist to a provider handover.

Lecturers
Andrés Gola Isasi
Info

Andrés Gola Isasi

Regulatory Business Development Director at ClarkeModet

Andres Gola Isasi is a Life Science Regulatory Compliance professional with extensive experience in the pharmaceutical, biotechnology and medical device industries. His expertise covers Regulatory Affairs, Quality Assurance, GMP compliance, investigations, Root Cause Analysis, CAPA systems, Human Factors and regulatory inspections.

Throughout his career, he has supported international life science organisations in quality and regulatory projects, including deviation investigations, CAPA improvement, inspection readiness, remediation activities and quality-system optimisation. He also combines his consulting experience with university teaching and professional training in Regulatory Affairs, Quality and Project Management.


Online Training – 1 module

22 March 2027 from 2:00 pm to 6:00 pm CET

Few days before the online training you will receive all details about the connection.

The course will proceed with a minimum number of participants. Should this number not be reached the registered participants will be notified one week prior to the commencement of the course.

Early Bird: € 525,00* (until 1 March 2027)

Ordinary: € 655,00*

Freelance – Individual – Academy – Public Administration: € 435,00*

* for Italian companies: +22% VAT

The fee includes: tuition, organizational office assistance, teaching materials and attendance certificate that will be sent after the training via e-mail.

Register
Early bird
Available until 01/03/2027
€525,00
Ordinaria
Available until 21/03/2027
€655,00
Freelance - Privato - Accademia - Pubblica Amministrazione
Available until 21/03/2027
€435,00
Clear

Accepted payment methods: Bank Transfer, Credit Card, PayPal.


Francesca Archetti
Francesca Archetti
Marketing & Sales Specialist
Printable Version
At the end of the training, you will be able to
Risultato atteso
Understand the role of PVAs in defining responsibilities and ensuring effective oversight of external pharmacovigilance partners
Risultato atteso
Identify key requirements for safety data exchange, including reporting timelines, receipt confirmation and escalation processes
Risultato atteso
Review operational clauses and assess compliance, recognising potential gaps in responsibilities, documentation and reporting processes
Risultato atteso
Evaluate critical aspects of provider transitions, including the handover of safety data and management of outstanding cases

<p><span>Online interactive training on Zoom platform. </span></p>
<p><em>LS Academy will provide the access link to the virtual platform a few days before the training.</em></p>

Online interactive training on Zoom platform. 

LS Academy will provide the access link to the virtual platform a few days before the training.

<p><span>Online interactive training on Zoom platform. </span></p>
<p><em>LS Academy will provide the access link to the virtual platform a few days before the training.</em></p>